Potential role of immunosenescence in cancer development
Tamàs Fülöp, Rami R. Kotb, Carl F Fortin et al. · Annals of the New York Academy of Sciences · 2010
The incidence and prevalence of most cancers increase with age. The reasons for this may include tumor escape mechanisms and decreased immunosurveillance, but most are caused by the time required for carcinogenesis, according to most scientists. The immune system is a unique mechanism of defense against pathogens and possibly cancers; however, there is a body of evidence that the immune system of the aged is eroded, a phenomenon termed immunosenescence. There is a growing interest in immunosenescence and how it may contribute to the increased number of cancers with aging. Each arm of the immune system, innate and adaptive, is altered with aging, contributing to increased tumorigenesis. Understanding the contribution of immunosenescence to cancer development and progression may lead to better interventions for the elderly.
Cited by 159 works. doi:10.1111/j.1749-6632.2009.05370.x
Authors
References
- Toll-Like Receptors
- Regulatory T Cells and Immune Tolerance
- Cancer despite immunosurveillance: immunoselection and immunosubversion
- Immune surveillance of tumors
- Chronic inflammation and oxidative stress in human carcinogenesis
- Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study
- Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study
- Inflamm‐ageing and lifelong antigenic load as major determinants of ageing rate and longevity
- Human innate immunosenescence: causes and consequences for immunity in old age
- The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age